The search for a cure for Alzheimer’s is far from over
Patent-mapping research suggests that innovation-led newcomers may already be on to something new
Read More
Author: PharmaTimes
AI and pharma sales
Alex Dale looks at where we are with AI and how it might help pharma sales
Read More
Sanofi’s Hugo Fry talks Brexit
Sanofi UK’s managing director Hugo Fry shares his thoughts on Brexit
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
